Published: Jun 5, 2026
Written by Klarity Editorial Team
Published: Jun 5, 2026

If you’re searching for mental health care—especially for ADHD, anxiety, depression, or insomnia—you’ve probably noticed an overwhelming number of telehealth providers. From household names like Teladoc to specialized platforms like Cerebral and Brightside, the landscape has changed dramatically over the past few years.
But here’s what many patients don’t realize: not all telehealth platforms are created equal—and some of the most popular ones have faced serious scrutiny, shut down entirely, or drastically limited what they can prescribe.
This comprehensive guide will help you understand the current state of online mental health care in 2026, compare the major providers side-by-side, and make an informed decision about where to seek treatment.
The COVID-19 pandemic accelerated telehealth adoption, particularly for mental health services. By 2021, dozens of startups were offering quick online evaluations and medication delivery for conditions like ADHD, anxiety, and depression—often for less than $100 per month.
However, the industry faced a major reckoning starting in 2022.
Two prominent ADHD telehealth companies—Done and Ahead—epitomized both the promise and the problems of fast-moving digital health.
Done Global, which focused exclusively on adult ADHD, grew rapidly by offering 30-minute video evaluations and quick prescriptions for stimulant medications like Adderall. By 2024, however, federal prosecutors indicted Done’s top executives for alleged illegal distribution of controlled substances, accusing the company of prioritizing profit over patient safety. The platform effectively shut down, leaving thousands of patients scrambling for alternative care.
Ahead (HelloAhead) shut its doors in mid-2022 amid operational and financial challenges, also leaving patients without continuity of care.
Even Cerebral—once valued at over $4 billion—faced intense scrutiny. In May 2022, Cerebral stopped prescribing stimulant ADHD medications to new patients after investigations revealed questionable prescribing practices. By late 2024, the company paid $3.6 million in settlements and dramatically refocused its business model.
These industry shakeups created important changes:
The good news? Legitimate, high-quality telehealth mental health care is still widely available—you just need to know where to look and what questions to ask.
The table below compares the leading telehealth platforms for mental health care as of early 2026, including what conditions they treat, what medications they can prescribe, where they operate, and how much they cost.
| Provider | Status | Conditions Treated | ADHD Stimulants? | Anti-Anxiety (Benzos)? | Sleep Meds? | Weight Loss (GLP-1)? | States Served | Pricing | Insurance? |
|---|---|---|---|---|---|---|---|---|---|
| Cerebral | 🟡 Limited operations | Depression, Anxiety, Insomnia, ADHD (non-stimulant only), Bipolar, PTSD | No (stopped May 2022) | No | No | No | 50 | $99-365/mo subscription | Limited |
| Done | 🔴 Shut down | ADHD | Yes (until 2024) | No | No | No | N/A | N/A | N/A |
| Ahead | 🔴 Closed 2022 | ADHD, Therapy | Yes (until 2022) | No | No | No | N/A | N/A | N/A |
| Brightside | 🟢 Active | Depression, Anxiety, PTSD, OCD, Insomnia (NO ADHD) | No | No | No | No | 50 | $95-349/mo | Yes (many plans) |
| Talkiatry | 🟢 Active | Full psychiatry: ADHD, Anxiety, Depression, Bipolar, etc. | Yes (when appropriate) | Yes (when needed) | Yes | No | 43 | $25-400/visit (typically co-pay) | Yes (in-network) |
| PlushCare | 🟢 Active | Primary care + mild mental health | No (policy restriction) | No | No | Yes (for obesity/diabetes) | 50 | $19.99/mo + $129/visit | Yes |
| MDLive | 🟢 Active | Urgent care, primary care, therapy/psychiatry | No | No | No | Yes (diabetes only) | 50 | $0-82/visit | Yes (widely) |
| Teladoc | 🟢 Active | General medical + mental health | No (explicit policy) | No | No | No | 50 | $75-200/visit | Yes (widely) |
| Amwell | 🟢 Active | Urgent care, psychiatry, women’s health | No | No | No | Limited | 50 | $79-120/visit | Yes |
| Hims/Hers | 🟢 Active | Lifestyle wellness: anxiety, depression, hair loss, ED, weight loss | No | No | No | Yes (weight programs) | 50 | $85/mo (medication) | No (cash/HSA) |
For ADHD Treatment with Stimulant Medications:Only Talkiatry routinely prescribes stimulant medications like Adderall or Vyvanse when clinically appropriate. All other major platforms either never offered this service or have discontinued it. This means adults seeking legitimate ADHD treatment with stimulants need to work with a full-service psychiatric provider, not a general telehealth app.
For Anxiety Without Benzodiazepines:Nearly all platforms will treat anxiety with non-controlled medications like SSRIs or SNRIs. Brightside explicitly focuses on this approach for depression and anxiety. However, if you need benzodiazepines like Xanax or Ativan for severe anxiety or panic disorder, you’ll need a psychiatry-focused service like Talkiatry.
For General Medical + Mental Health:Platforms like Teladoc, MDLive, and PlushCare excel at treating common medical problems (sinus infections, UTIs, high blood pressure) alongside mild mental health concerns. However, they explicitly cannot prescribe controlled substances and aren’t ideal for complex psychiatric needs.
For Cost-Conscious Patients:Insurance-accepting platforms like Talkiatry, MDLive, and Teladoc often result in the lowest out-of-pocket costs if you have good coverage (sometimes just a $10-30 co-pay). Cash-pay subscription services like Cerebral or Brightside may be more expensive over time at $95-365 per month.
All major platforms now operate nationwide or in nearly all 50 states. However, state-specific regulations affect what providers can do:
This is the question patients ask most: ‘Why won’t Teladoc/Brightside/PlushCare prescribe Adderall or Xanax?’
The answer involves both regulatory caution and business risk management.
Federal law (the Ryan Haight Act) traditionally required an in-person medical evaluation before prescribing Schedule II-IV controlled substances. During COVID-19, the DEA waived this requirement, enabling telehealth ADHD and anxiety treatment to boom.
However, several factors led most platforms to restrict or ban controlled substance prescribing:
As a result, most direct-to-consumer telehealth platforms adopted blanket policies against prescribing:
Full-service psychiatric telehealth platforms like Talkiatry employ board-certified psychiatrists who can prescribe any appropriate medication, including controlled substances. These platforms typically:
This is where Klarity Health offers a valuable middle ground. Unlike general telehealth apps that refuse all controlled substances, Klarity’s licensed psychiatric providers can prescribe necessary ADHD medications, sleep aids, and anxiety medications when clinically appropriate—following proper evaluation and ongoing monitoring. At the same time, Klarity offers more flexibility than traditional insurance-based psychiatry: faster appointments (often within days), transparent pricing for both insured and cash-pay patients, and the ability to see the same provider consistently.
One surprising development in telehealth has been the explosion of weight loss medication services, particularly GLP-1 agonists like Wegovy (semaglutide) and Zepbound (tirzepatide).
Unlike controlled substances, these medications don’t fall under DEA restrictions, making them easier to prescribe via telehealth. Several platforms have launched dedicated weight loss programs:
However, the FDA issued warnings in 2025 about telehealth companies selling compounded semaglutide (custom-made versions) when brand-name drugs were available, creating regulatory uncertainty.
For patients seeking comprehensive wellness care—including mental health, metabolic health, and weight management—this is an emerging area where specialized platforms may offer advantages over traditional providers.
Beyond official policies and pricing, what matters most is actual patient experience. Here’s what reviews and complaints reveal about major platforms:
Common complaints:
Positives:
Common complaints:
Positives:
Common complaints:
Positives:
Common complaints:
Positives:
Common complaints:
Positives (historical):
The Done case illustrates why convenience without quality is a dangerous trade-off in healthcare.
Given the current landscape, where does Klarity Health provide unique value?
Klarity specializes in areas where general telehealth falls short:
Unlike subscription models that charge monthly regardless of usage, Klarity offers:
This pricing structure means you pay for what you need, when you need it—not a recurring charge when you’re stable and doing well.
While Talkiatry and traditional psychiatrists often have 2-4 week wait times, Klarity typically offers appointments within days. For patients in crisis or needing urgent medication adjustments, this speed matters enormously.
Unlike general telehealth platforms where you see different providers each visit, Klarity emphasizes seeing the same provider consistently. This continuity allows your provider to:
Klarity learned from the mistakes of Done, Cerebral, and others. The platform emphasizes:
This balanced approach addresses the legitimate need for medications like stimulants while avoiding the ‘pill mill’ perception that damaged other platforms.
Here’s a decision framework based on your specific needs:
If you need ADHD treatment with stimulant medications:
If you have depression or anxiety but want to avoid controlled substances:
If you need simple prescription refills or mild conditions:
If you need comprehensive care for multiple conditions (mental health + weight + hormones):
If cost is your primary concern:
Several trends will shape telehealth mental health care in the coming year:
The temporary DEA waiver allowing telehealth prescribing of controlled substances without an in-person visit has been extended through late 2025, but its future beyond that is uncertain. This could mean:
What this means for you: Choose a platform with flexibility to adapt to regulatory changes, potentially including in-person options or partnerships with local clinics.
Expect more mergers, acquisitions, and potential shutdowns of smaller players. Health insurance companies and large healthcare systems are buying telehealth platforms or building their own.
What this means for you: Prioritize platforms with stable backing and established track records over brand-new startups with unproven business models.
Many platforms are implementing:
What this means for you: Better outcomes and more personalized care, but also privacy considerations (understand how your data is used).
The lines are blurring between mental health, metabolic health, and general wellness. Expect platforms to offer more integrated care addressing:
Before choosing a telehealth mental health platform, ask these essential questions:
The telehealth mental health industry has matured significantly since its pandemic boom. The painful lessons learned from Done, Cerebral, and others have created a more responsible, patient-centered landscape.
The key takeaways:
The most important advice: prioritize quality and safety over convenience. The fastest prescription isn’t always the right prescription. Look for platforms that:
Your mental health deserves thoughtful, personalized care from qualified professionals—and in 2026, that care is available through telehealth when you choose the right provider.
If you’re seeking comprehensive mental health treatment for ADHD, anxiety, depression, insomnia, or other conditions—with provider availability within days, transparent pricing, and acceptance of both insurance and cash payment—Klarity Health offers the specialized care you need in a convenient telehealth format.
Visit Klarity Health to complete a brief assessment and schedule your first appointment with a licensed psychiatric provider.
AP News – ‘Top executives of telehealth company accused of putting profit over patients’ (DOJ indictment of Done Global), June 14, 2024. https://apnews.com/article/498cb907623565ee680b33b1367efb84
TIME Magazine – ‘Why Online Therapy Startups Are Falling Short on Their Promise,’ November 1, 2022. https://time.com/6225361/telehealth-startups-cerebral-done-ahead/
TechTarget Healthcare IT News – ‘Pushing ADHD telehealth prescriptions costs Cerebral millions,’ November 6, 2024. https://www.techtarget.com/virtualhealthcare/news/366615298/Pushing-ADHD-telehealth-prescriptions-costs-Cerebral-millions
Telehealth & Telecare Aware – Done Health CEO indicted, June 19, 2024. https://telecareaware.com/2024/06/
AP News – ‘FDA launches crackdown on telehealth companies pushing weight-loss drugs,’ September 16, 2025. https://apnews.com/article/9c08db3481dcfd67c433fad1ae07d941
RESEARCH CURRENCY STATEMENT
Verified as of: January 4, 2026
Providers verified active: Cerebral, Brightside, Talkiatry, PlushCare, MDLive, Teladoc, Amwell, Hims/Hers
Key sources checked: 2024 DOJ press releases; 2025 industry news (TechTarget, AP); official provider policies (Teladoc, PlushCare, Brightside); competitor reviews and recent analyses (2025)
Find the right provider for your needs — select your state to find expert care near you.